SCHEMBL27768263

SCHEMBL27768263

CC(Br)(CCCCCCC(=O)O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.49
HDAC4 P56524 2/20 0.49
HDAC1 Q13547 2/20 0.49
HDAC7 Q8WUI4 2/20 0.49
HDAC2 Q92769 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
HDAC9 Q9UKV0 2/20 0.49
HDAC5 Q9UQL6 2/20 0.49
MAPT P10636 2/20 0.49
RXFP1 Q9HBX9 1/20 0.49
CYP2C19 P33261 1/20 0.46
HIF1A Q16665 1/20 0.46
TBXAS1 P24557 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAPK1 P28482 1/20 0.43
ADRA1A P35348 1/20 0.43
SLC6A3 Q01959 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27555080 0.87 ALDH1A1 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17267375 0.82 CYP2C19 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27532469 0.81 PTGS1 (0.42) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL1635914 0.80 HDAC3 (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9449505 0.79 HDAC3 (0.45) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9449951 0.79 HDAC3 (0.45) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1633685 0.78 KIF11 (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1581587 0.78 SIGMAR1 (0.40) MAPK1SMN1; SMN2
SCHEMBL28255218 0.78 SIGMAR1 (0.40) MAPK1SMN1; SMN2
SCHEMBL7005923 0.78 HDAC11 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101426763-A Sulfide and disulfide compounds and compositions for cholesterol management and related uses ESPERION THERAPEUTICS INC (US) 2009-05-06 CN disclosed